Highlights

  • RocketDNA has entered into a binding agreement to acquire the remaining 40% of RocketDNA (WA) Pty Ltd.
  • The company already owns 60% of RocketDNA (WA) and will move to 100% ownership on completion.
  • The transaction consideration is AUD 1.0 million, to be paid entirely through new RocketDNA shares with no cash component.
  • RocketDNA will issue 41,767,605 shares, representing approximately 3.5% of current issued capital on an indicative basis.

RocketDNA Ltd (ASX:RKT) shares moved higher during the morning session on 17 June 2026, rising 4.35% to AUD 0.024 after the company announced a binding agreement to acquire the remaining 40% interest in RocketDNA (WA) Pty Ltd. The stock has also gained 140.00% over the past year, keeping investor attention on the company’s operational and corporate developments.

The update appears favourable from a structural and ownership perspective, as the transaction will move RocketDNA from 60% to 100% ownership of a subsidiary it already controls and consolidates. However, the company made clear that the deal does not change its operations, customers, strategy, reported consolidated revenue, reported net assets or reported profit after tax. Instead, the transaction is mainly aimed at removing the 40% non-controlling interest and simplifying the broader group structure.

About RocketDNA

RocketDNA is an ASX-listed technology services company specialising in AI-powered drone solutions. The company provides drone-based data services and technology solutions across aerial surveying, mapping, security, surveillance and asset inspection.

Its services are used by enterprise customers in sectors such as mining, agriculture and engineering. RocketDNA’s business model includes fully outsourced, AI-driven solutions where drone systems are operated remotely, allowing customers to focus on ground operations while receiving fast data turnaround.

The company generates revenue through both multi-year contracts and short-term projects. Its client base includes major Tier 1 and Tier 2 mining companies, including Rio Tinto, BHP, South32, Newmont, Vault Minerals and Seriti Coal. RocketDNA operates mainly in Australia and Africa, with regional offices in Perth, Johannesburg and Accra.

Full Ownership Move Simplifies Group Structure

The latest announcement centres on RocketDNA’s decision to acquire the remaining minority interest in RocketDNA (WA), its established Western Australian operating subsidiary.

RocketDNA first acquired a 60% interest in the subsidiary, then known as Arvista Pty Ltd, in September 2021. Since then, the company has controlled and consolidated the subsidiary within its group accounts.

RocketDNA (WA) is important to the company’s Australian operations, as it is the entity through which most of the Group’s Australian revenue is recognised.

By acquiring the remaining 40%, RocketDNA will remove the non-controlling interest currently reported in the subsidiary and move to full ownership of the Western Australian business.

The company emphasised that the transaction changes only the ownership of the subsidiary. It does not alter the company’s customer base, operating model, strategy or reported consolidated revenue.

AUD 1 Million Deal to Be Paid Entirely in Shares

RocketDNA has agreed to acquire the remaining 40% interest for AUD 1.0 million.

Importantly, the consideration will be paid entirely through the issue of new fully paid ordinary RocketDNA shares, meaning there is no cash payment attached to the transaction.

The shares will be issued at the 20-day volume weighted average price of RocketDNA shares up to 15 June 2026, which was AUD 0.023942 per share.

Based on this pricing, RocketDNA will issue 41,767,605 new shares. The company stated that this represents approximately 3.5% of its current issued capital on an indicative basis.

The consideration shares will be issued under the company’s existing placement capacity under ASX Listing Rule 7.1. RocketDNA also clarified that the acquisition is a separately negotiated purchase and not an exercise of the call option arrangements entered into in 2021.

Founders Remain Aligned Through Escrowed Equity

The shares issued as consideration will be held in voluntary escrow for 12 months.

This structure is notable because some of the original founders of the subsidiary are among the vendors and continue to contribute to RocketDNA’s operations.

The vendors are Investmin Pty Ltd, the McKern Family Trust and the McLeay Family Trust.

Mr Evan McKern, a co-founder of the subsidiary acquired in 2021, holds a senior operational role as Technical Director within the RocketDNA business. Through the McKern Family Trust, he holds a 16% interest in RocketDNA (WA). He will receive 40% of the consideration shares, representing shares valued at AUD 0.4 million, which will be held in escrow for 12 months.

Mr Shane McLeay, the other co-founder, is a director of RocketDNA (WA) and provides insight into the Western Australian mining industry. Through the McLeay Family Trust, he also holds a 16% interest in RocketDNA (WA). He will also receive 40% of the consideration shares, representing shares valued at AUD 0.4 million, subject to the same 12-month voluntary escrow.

RocketDNA noted that neither of these vendors is a director of RocketDNA Ltd and they are not related parties of the company for the purposes of Chapter 2E of the Corporations Act or ASX Listing Rule 10.11. As a result, shareholder approval is not required on that basis.

The company also stated that the vendors’ interests were disclosed to and managed by the Board, including appropriate abstention in relation to relevant subsidiary approvals.

No Change to Operations or Consolidated Revenue

While the market responded positively to the update, RocketDNA’s announcement was careful to distinguish the ownership change from an operational change.

The company said the acquisition does not change operations, customers, strategy, reported consolidated revenue, reported net assets or reported profit after tax.

This is because RocketDNA already controls and consolidates RocketDNA (WA). The main accounting and structural change is the removal of the reported 40% non-controlling interest in the subsidiary.

For investors, this means the transaction is not being positioned as a revenue expansion deal. Instead, it is a simplification of the ownership structure of a business already operating within RocketDNA’s group.

Completion Subject to Conditions

The transaction remains subject to customary conditions, including no material adverse change.

These conditions must be satisfied or waived within 90 days.

One of the conditions includes the amendment of an intercompany loan provided by Entech Pty Ltd, which is owned and operated by Mr Shane McLeay. The company said the loan is to be amended onto commercial terms.

Once completion occurs, RocketDNA will own 100% of RocketDNA (WA), and the consideration shares will be issued to the vendors.

The company also included a forward-looking statement, noting that completion of the proposed acquisition remains subject to the satisfaction or waiver of conditions and may not occur.

Management Calls Deal a Housekeeping Step

RocketDNA Managing Director and CEO Christopher Clark described the move to full ownership of the Western Australian subsidiary as a sensible housekeeping step.

He noted that RocketDNA already controls and consolidates the entity, meaning there is no operational change from the transaction. Instead, the company is removing the remaining minority interest through what management described as modest scrip consideration.

The CEO also highlighted that the founders of the business, who continue to contribute to RocketDNA, are taking their consideration in escrowed RocketDNA shares. According to the company, this structure aligns those long-standing operators with RocketDNA shareholders.

Why Investors Are Watching the Update

RocketDNA’s share price rise appears connected to the company’s move to simplify its corporate structure and secure full ownership of a subsidiary that plays an important role in its Australian revenue base.

The deal also avoids a cash outflow, as the AUD 1.0 million consideration will be settled entirely in shares. This may be relevant for investors tracking how technology and services companies manage capital while pursuing structural improvements.

The 12-month voluntary escrow also provides a degree of alignment, as the vendors receiving shares will not be able to freely trade those shares immediately.

At the same time, investors should note the company’s clear statement that the transaction does not change its operations or reported consolidated revenue. The update is therefore best understood as a group structure and ownership clean-up rather than a direct operating expansion.

What This Means for Investors

RocketDNA’s latest update signals a move toward full ownership of a subsidiary already controlled and consolidated by the company. By acquiring the remaining 40% of RocketDNA (WA), the company will remove the non-controlling interest, simplify its group structure and fully align the ownership of an important Western Australian operating entity.

The transaction is being completed with no cash consideration, using AUD 1.0 million of newly issued RocketDNA shares priced at the 20-day VWAP up to 15 June 2026. The escrow arrangements also keep the vendors aligned with shareholders for at least 12 months after completion.

Investors are likely to monitor completion of the transaction within the stated 90-day period, along with any further updates on the company’s drone-based data services operations across Australia and Africa.